Key result
Extreme postprocedural hsCRP levels linked to ~2-fold higher all-cause mortality in ACS.
Why the study?
Inflammation has dual effects after myocardial infarction, but whether postprocedural hsCRP has a nonlinear association with mortality in ACS patients treated by PCI remained unclear.
Does postprocedural hsCRP level associate with mortality in ACS patients treated by PCI?
Cohort (n=3,940)
No
Does postprocedural hsCRP level associate with mortality in ACS patients treated by PCI?
Both low and high postprocedural hsCRP levels are associated with an increased risk of death in ACS patients treated by PCI, suggesting a J-shaped relationship where moderate inflammation may be protective.
Answers are grounded in this paper and cite their sources.
J-shaped hsCRP-mortality link post-PCI in ACS may be hypothesis-generating; leaves open whether targeting moderate inflammation improves outcomes.
Background . Inflammation poses dual effects after myocardial infarction, but robust evidence shows that high-sensitivity C-reactive protein (hsCRP), as an inflammatory marker, is constantly associated with worse outcomes. This study is aimed at investigating the probable nonlinear association between postprocedural hsCRP and mortality in patients with acute coronary syndromes (ACS) treated by percutaneous coronary intervention (PCI). Methods . A total of 3940 consecutive ACS patients treated by PCI with postprocedural hsCRP measurements were retrospectively recruited. Patients were stratified into 5 groups according to quintiles of hsCRP. Cox regression with adjustments for multiple covariates was used for outcome analysis. Restricted cubic spline (RCS) analysis was used to allow possible nonlinear associations. The primary outcome was all-cause death. Results . During a median follow-up of 727 days, mortality occurred in 207 (5.3%) patients. Adjusted hazard ratio (HR) was higher in the lowest (<2.26 mg/L, HR: 1.90, 95% confidence interval (CI): 1.08-3.33; P=0.025), second highest (10.16-12.56 mg/L, HR: 1.86, 95% CI: 1.09-3.16; P=0.023), and highest quintiles (≥12.56 mg/L, HR: 2.02, 95% CI: 1.21-3.36; P=0.007) of postprocedural hsCRP, compared to the second lowest quintile (2.26-4.85 mg/L). RCS analysis depicted a J-shaped association between postprocedural hsCRP and mortality (P for nonlinearity=0.004). Similar association was observed between hsCRP and cardiac death (P for nonlinearity=0.014), but not for noncardiac mortality (P for nonlinearity=0.228). Conclusions . Both low and high postprocedural hsCRP were associated with higher risk of death in ACS patients treated by PCI.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2020) conducted a cohort in Acute coronary syndromes (ACS) (n=3,940). Postprocedural hsCRP vs. Second lowest quintile of hsCRP (2.26-4.85 mg/L) was evaluated on All-cause mortality (HR 2.02, 95% CI 1.21-3.36, p=0.007). Both low and high postprocedural hsCRP levels were associated with an increased risk of all-cause mortality compared to intermediate levels in ACS patients.
Synapse has enriched 10 related papers. Consider them for comparative context: